Literature DB >> 10959240

Peripheral neuropathy in chronic respiratory insufficiency.

S Jann1, A Gatti, S Crespi, J Rolo, S Beretta.   

Abstract

Peripheral neuropathy commonly occurs in patients with chronic obstructive lung disease (COPD). We report the presence of peripheral neuropathy in 19 of our 30 COPD patients (63.3%): 7 patients had clinical signs of a symmetric motor and sensory polyneuropathy, 12 patients had only subclinical evidence of peripheral nervous system involvement. Neurophysiological studies showed low amplitude compound muscle action potentials (CMAP) and sensory action potentials (SAP) with only slight reduction of nerve conduction velocity in affected patients: these data confirm an axonal polyneuropathy. The severity of the peripheral nervous system involvement in COPD patients was correlated with hypercapnia, the degree of disability and thus with the severity of COPD. Hypoxia, age and duration of the disease were not related with the presence of polyneuropathy. Improvement of respiratory function produced slight but progressive improvement of neurological symptoms. Within one year, also neurophysiological studies revealed a progressive and statistically significant improvement in CMAP and SAP amplitude and motor and sensory conduction velocity and, in some cases, normal electromyography.

Entities:  

Mesh:

Year:  1998        PMID: 10959240

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  8 in total

Review 1.  Chronic obstructive pulmonary disease: consequences beyond the lung.

Authors:  Dinesh Shrikrishna; Nicholas S Hopkinson
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

Review 2.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

3.  Chronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study.

Authors:  Nora A Visser; Nicolette C Notermans; Ferdinand Teding van Berkhout; Leonard H van den Berg; Alexander Fje Vrancken
Journal:  Chron Respir Dis       Date:  2016-03-15       Impact factor: 2.444

4.  Neurophysiological aspects and their relationship to clinical and functional impairment in patients with chronic obstructive pulmonary disease.

Authors:  Carolina Chiusoli de Miranda Rocco; Luciana Maria Malosá Sampaio; Roberto Stirbulov; João Carlos Ferrari Corrêa
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

5.  Correlation between optic nerve involvement and chronic obstructive pulmonary disease.

Authors:  Haleh Mikaeili; Mohammad Yazdchi; Shiva Solahaye Kahnamouii; Elyar Sadeghi-Hokmabadi; Reshad Mirnour
Journal:  Clin Ophthalmol       Date:  2015-02-09

Review 6.  Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review.

Authors:  Kristin Samuelsson; Rayomand Press
Journal:  Front Neurol       Date:  2018-02-12       Impact factor: 4.003

7.  Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness.

Authors:  Francois Alexandre; Nelly Héraud; Emilie Tremey; Nicolas Oliver; Dominique Bourgouin; Alain Varray
Journal:  BMC Pulm Med       Date:  2020-01-03       Impact factor: 3.317

8.  The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.

Authors:  K Kahnert; M Föhrenbach; T Lucke; P Alter; F T Trudzinski; R Bals; J I Lutter; H Timmermann; S Söhler; S Förderreuther; D Nowak; H Watz; B Waschki; J Behr; T Welte; C F Vogelmeier; R A Jörres
Journal:  Respir Res       Date:  2020-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.